Stryker, Johnson & Johnson and Zimmer Biomet posted their third-quarter financial results for 2024 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $5.5 billion (+11.9%)
Orthopedics: $2.3 billion (10.7%)
Hips: $420 million (+15.9%)
Knees: $570 million (+10.6%)
Spine: $304 million (+4.6%)
Net gain: $834 million
Total sales: $1.8 billion (+4%)
Hips: $481.5 million (+3.5%)
Knees: $745.1 million (+5.5%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $464.2 million (+7.3%)
Net earnings: $249.1 million
Total sales: $22.5 billion (+5.2%)
Orthopedic: $2.2 billion (+1.2%)
Spine, sports and other: $696 million (-1.9%)
Hips: $381 million (+1.7%)
Knees: $352 million (+4%)
Net earnings: $2.7 billion